Mylan Laboratories Limited has received a risk category 1 ranking from the WHO Expert Review Panel for its generic injectable, medroxyprogesterone acetate depot 150mg/ml.
News & Events
- From Concept Foundation: July 2019
- Concept Foundation announces A. Metin Gülmezoglu as its new Executive Director
- Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial results released
- World Preeclampsia Day – Access to quality magnesium sulfate to reduce maternal mortality
- WHO/UNICEF/UNFPA Joint Statement: Appropriate Storage and Management of Oxytocin – a Key Commodity for Maternal Health